Correlation Between Cullinan Oncology and Tenaya Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Tenaya Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Tenaya Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Tenaya Therapeutics, you can compare the effects of market volatilities on Cullinan Oncology and Tenaya Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Tenaya Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Tenaya Therapeutics.
Diversification Opportunities for Cullinan Oncology and Tenaya Therapeutics
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cullinan and Tenaya is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Tenaya Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenaya Therapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Tenaya Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenaya Therapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Tenaya Therapeutics go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Tenaya Therapeutics
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Tenaya Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 2.43 times less risky than Tenaya Therapeutics. The stock trades about -0.27 of its potential returns per unit of risk. The Tenaya Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 208.00 in Tenaya Therapeutics on August 28, 2024 and sell it today you would earn a total of 88.00 from holding Tenaya Therapeutics or generate 42.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Tenaya Therapeutics
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Tenaya Therapeutics |
Cullinan Oncology and Tenaya Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Tenaya Therapeutics
The main advantage of trading using opposite Cullinan Oncology and Tenaya Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Tenaya Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenaya Therapeutics will offset losses from the drop in Tenaya Therapeutics' long position.| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. HCW Biologics | Cullinan Oncology vs. Scpharmaceuticals | Cullinan Oncology vs. Milestone Pharmaceuticals |
| Tenaya Therapeutics vs. Bicycle Therapeutics | Tenaya Therapeutics vs. IGM Biosciences | Tenaya Therapeutics vs. Monte Rosa Therapeutics | Tenaya Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |